I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 17 studies | 53% ± 20% | |
| cardiac muscle cell | 5 studies | 22% ± 6% | |
| Mueller cell | 4 studies | 26% ± 10% | |
| epithelial cell | 4 studies | 27% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 17 studies | 53% ± 20% | |
| cardiac muscle cell | 5 studies | 22% ± 6% | |
| Mueller cell | 4 studies | 26% ± 10% | |
| epithelial cell | 4 studies | 27% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 2829.54 | 180 / 180 | 99% | 25.85 | 427 / 430 |
| thymus | 99% | 2530.56 | 646 / 653 | 99% | 17.02 | 598 / 605 |
| kidney | 100% | 5001.83 | 89 / 89 | 97% | 104.25 | 872 / 901 |
| pancreas | 99% | 1931.68 | 325 / 328 | 97% | 21.38 | 172 / 178 |
| brain | 99% | 10892.33 | 2628 / 2642 | 94% | 40.49 | 666 / 705 |
| stomach | 97% | 4573.11 | 349 / 359 | 97% | 19.66 | 276 / 286 |
| intestine | 96% | 2508.57 | 925 / 966 | 98% | 20.51 | 515 / 527 |
| lung | 98% | 2502.71 | 566 / 578 | 93% | 17.70 | 1072 / 1155 |
| uterus | 95% | 2008.83 | 161 / 170 | 91% | 20.23 | 418 / 459 |
| esophagus | 67% | 1006.75 | 968 / 1445 | 93% | 20.65 | 170 / 183 |
| adrenal gland | 95% | 1714.47 | 245 / 258 | 65% | 12.21 | 149 / 230 |
| bladder | 57% | 1051.19 | 12 / 21 | 89% | 17.49 | 449 / 504 |
| liver | 70% | 1109.23 | 158 / 226 | 66% | 12.81 | 267 / 406 |
| prostate | 94% | 2392.83 | 231 / 245 | 40% | 3.05 | 203 / 502 |
| breast | 60% | 967.64 | 274 / 459 | 73% | 10.94 | 821 / 1118 |
| eye | 0% | 0 | 0 / 0 | 100% | 33.83 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.88 | 1 / 1 |
| heart | 99% | 12431.52 | 853 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 4800.66 | 1317 / 1335 | 0% | 0 | 0 / 0 |
| skin | 18% | 200.87 | 324 / 1809 | 80% | 18.36 | 379 / 472 |
| spleen | 98% | 2083.61 | 236 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 21.44 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 3.47 | 15 / 29 |
| adipose | 46% | 711.91 | 556 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 12% | 160.97 | 99 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 6.00 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031643 | Biological process | positive regulation of myelination |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | CDK18 |
| Protein name | Cyclin dependent kinase 18 Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3) |
| Synonyms | PCTAIRE3 PCTK3 |
| Description | FUNCTION: May play a role in signal transduction cascades in terminally differentiated cells. |
| Accessions | ENST00000443813.6 Q07002 ENST00000506784.5 [Q07002-3] ENST00000419301.1 ENST00000360066.6 [Q07002-2] A0A0A0MSJ6 ENST00000429964.7 [Q07002-2] D6R9B0 |
